In many of these studies decreased tumor burden and prolonged survival was abolished when mice were depleted of NK and/or CD8+ T cells, demonstrating these IL-15 responsive effector cells were providing the anti-tumor effects. The gene discussed is CD8A; the disease is neoplasm.